MSR
Main Street Research Portfolio holdings
AUM
$1.61B
This Quarter Return
-1.67%
1 Year Return
+40.97%
3 Year Return
+155.31%
5 Year Return
+332.91%
10 Year Return
+1,043.12%
AUM
$971M
AUM Growth
+$971M
(+55%)
Cap. Flow
+$378M
Cap. Flow
% of AUM
38.99%
Top 10 Holdings %
Top 10 Hldgs %
37.84%
Holding
101
New
8
Increased
37
Reduced
25
Closed
10
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$31.8M |
| 2 |
Linde
LIN
|
$21.9M |
| 3 |
Palo Alto Networks
PANW
|
$21.4M |
| 4 |
Adobe
ADBE
|
$21.3M |
| 5 |
Novo Nordisk
NVO
|
$21.2M |
Top Sells
| 1 |
Elevance Health
ELV
|
$13.5M |
| 2 |
Enbridge
ENB
|
$10.4M |
| 3 |
American Electric Power
AEP
|
$9.65M |
| 4 |
General Dynamics
GD
|
$1.35M |
| 5 |
McKesson
MCK
|
$1.1M |
Sector Composition
| 1 | Technology | 28.74% |
| 2 | Financials | 14.5% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Staples | 10.19% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Abbott
ABT
$231B
| $357K | 0.04% |
3,685
-1,218
| -25% | -$118K |
|
77
Veeva Systems
VEEV
$44B
| $326K | 0.03% |
1,600
| – | – |
|
78
Ulta Beauty
ULTA
$22.1B
| $322K | 0.03% |
806
-20
| -2% | -$7.99K |
|
79
PepsiCo
PEP
$204B
| $313K | 0.03% |
1,850
-170
| -8% | -$28.8K |
|
80
Nike
NKE
$114B
| $300K | 0.03% |
3,127
| – | – |
|
81
Xylem
XYL
$34.5B
| $296K | 0.03% |
3,250
| – | – |
|
82
Deere & Co
DE
$129B
| $278K | 0.03% |
734
+47
| +7% | +$17.8K |
|
|
83
American Electric Power
AEP
$59.4B
| $268K | 0.03% |
3,567
-128,241
| -97% | -$9.65M |
|
84
Albemarle
ALB
$9.99B
| $264K | 0.03% |
1,550
| – | – |
|
85
SPDR Dow Jones Industrial Average ETF Trust
DIA
$39.9B
| $263K | 0.03% |
782
+32
| +4% | +$10.7K |
|
86
Intel
INTC
$107B
| $251K | 0.03% |
7,050
+50
| +0.7% | +$1.78K |
|
87
Pfizer
PFE
$141B
| $248K | 0.03% |
7,466
+250
| +3% | +$8.29K |
|
88
Local Bounti
LOCL
$53.3M
| $114K | 0.01% |
46,394
| – | – |
|
89
Banco Santander
SAN
$141B
| $66.7K | 0.01% |
17,739
| – | – |
|
90
Better Home & Finance Holding
BETR
$346M
| $14.1K | ﹤0.01% |
+29,373
| New | +$14.1K |
|
91
Sangamo Therapeutics
SGMO
$157M
| $6K | ﹤0.01% |
10,000
| – | – |
|
92
Danaher
DHR
$147B
| – | – |
-869
| Closed | -$209K |
|
|
93
Enbridge
ENB
$105B
| – | – |
-280,959
| Closed | -$10.4M |
|
94
Entegris
ENTG
$12.7B
| – | – |
-1,968
| Closed | -$218K |
|
95
Edwards Lifesciences
EW
$47.8B
| – | – |
-2,200
| Closed | -$208K |
|
96
Gilead Sciences
GILD
$140B
| – | – |
-2,604
| Closed | -$201K |
|
97
NextEra Energy, Inc.
NEE
$148B
| – | – |
-5,697
| Closed | -$423K |
|
98
ResMed
RMD
$40.2B
| – | – |
-1,200
| Closed | -$262K |
|
99
RTX Corp
RTX
$212B
| – | – |
-3,171
| Closed | -$311K |
|
100
AT&T
T
$209B
| – | – |
-13,699
| Closed | -$218K |
|